博文
2017年最新克罗恩病治疗指南
|||
2017年最新克罗恩病治疗指南
疾病活动度评分—CDAI：
The index of clinical disease activity of CD is represented by the CDAI(Table 3) and the Harvey-Bradshaw index (HBI) (Table 4). CDAI is widely used in many clinical studies and clinical fields. A CDAI of <150 is classified as remission, 150 to <220 as mild activity, 220 to <450 as moderate activity, and ≥450 as severe activity. On the other hand, HBI is a disease activity index designed to simplify the complex CDAI, and consists of only clinical parameters. An HBI of <5 is classified as remission, 5 to <8 as mild activity, 8 to <16 as moderate activity, and ≥16 as severe activity.
2. 疾病活动度评分—HBS：
3. 蒙特利尔分类：
4. 诱导缓解治疗—轻中度CD：
5. 诱导缓解治疗—中重度CD：
6. 难治性CD药物治疗：
7. 维持治疗—5-ASA诱导：
8. 维持治疗—激素诱导：
9. 维持治疗—anti-TNF诱导：
10. 维持治疗—MTX诱导：
11. 维持治疗中再复发：
https://blog.sciencenet.cn/blog-661795-1037959.html
上一篇：PNAS——葡萄糖神经酰胺合成酶抑制剂有助于治疗突触核蛋白病
下一篇：Nature——使用深度学习算法可以早期预测儿童自闭症的发生
